Acurx Pharmaceuticals
ACXP
ACXP
18 hedge funds and large institutions have $1.32M invested in Acurx Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
67% less capital invested
Capital invested by funds: $3.94M → $1.32M (-$2.62M)
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$28K | |
| 2 | +$26.9K | |
| 3 | +$22.5K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$16.2K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$15.2K |
Top Sellers
| 1 | -$1.02M | |
| 2 | -$3.89K | |
| 3 | -$1.14K | |
| 4 |
SIC
Salem Investment Counselors
Winston Salem,
North Carolina
|
-$265 |